SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs Post author:Sam Post published:January 30, 2018 Post category:BioPharma Vical announced its restructuring late Tuesday. Source: BioSpace You Might Also Like Bone Therapeutics To Participate In Upcoming Key Investor Conferences March 9, 2017 <b>Affinity Bio</b> Partners And <b>Affinity Bioceuticals</b> September 20, 2017 Dova Pharma Reports Second Quarter 2017 Operating and Financial Results August 10, 2017